Go to main content

  1. Home
  2. UK Vaccine Network - MRC/BBSRC Intramural Centre Vaccine Development Projects

UK - Department of Health and Social Care (DHSC)

UK Vaccine Network - MRC/BBSRC Intramural Centre Vaccine Development Projects

Disclaimer: The data for this page has been produced from IATI data published by UK - Department of Health and Social Care (DHSC). Please contact them if you have any questions about their data.

Programme Data Last Updated: 25/08/2021

IATI Identifier: GB-GOV-10-UKVN-NETSCC

Description

The Prime Minister established the UK Vaccine Network in June 2015 to ensure that the UK was at the forefront of the global fight against future disease outbreaks. The UK Vaccine Network has identified a range of human diseases with epidemic potential in low and middle income countries (LMICs) for which the development of Vaccine Products is a priority. The Department of Health and Social Care collaborated with the Biotechnology and Biological Sciences Research Council and the Medical Research Council, both arms' length bodies of the Department of Business, Energy and Industrial Strategy, in running the 2016 competition which aims to support vaccine research to tackle UKVN-identified priority pathogens. This competition was wholly funded by Official Development Assistance and therefore projects must be primarily for the benefit of LMICs. The successful projects are being managed by the National Institute for Health Research. The Department of Health and Social Care made around £12 million available to fund six successful projects.

Description

This funding supports six projects seeking to develop candidate vaccines and vaccine platform technologies at late preclinical and early clinical stages against pathogens with epidemic potential in low and middle income countries. The UK Vaccine Network has identified 12 pathogens as a priority: Chikungunya, Crimean-Congo Haemorrhagic Fever, Ebola, Hantavirus, Lassa, Marburg, Middle East Respiratory Syndrome, Nipah, Plague, Q Fever, Rift Valley Fever and Zika. The aim of this funding is to progress the development of vaccines for these priority diseases, ultimately to support an effective and rapid response during future outbreaks of disease.

Description

Populations of the low and middle income countries where outbreaks of the UK Vaccine Network 12 priority pathogens occur.

Status - Implementation More information about Programme status
Programme Spend More information about Programme funding
Participating Organisation(s) More information about implementing organisation(s)

This site uses cookies

We use Google Analytics to measure how you use the website so we can improve it based on user needs. Google Analytics sets cookies that store anonymised information about how you got to the site, the internal pages you visit, how long you spend on each page and what you click on while you're visiting the site. Read more